Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.

被引：0
|
作者：
Pirker, R
Jaeger, U
Pohl, G
Stranzl, T
Simonitsch, I
Kaider, A
Skrabs, C
Filipits, M
机构：
[1] Univ Vienna, Dept Internal Med 1, Vienna, Austria
[2] Univ Vienna, Inst Clin Pathol, Vienna, Austria
[3] Univ Vienna, Dept Med Comp Sci, Vienna, Austria
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
528
引用
收藏
页码：126A / 126A
页数：1
相关论文
共 50 条
  • [21] Nur 77 is a poor prognostic factor in diffuse large B-cell lymphoma
    Almiski, S.
    Razumilava, N.
    Kurrer, M.
    Frank, J.
    Levi, E.
    LABORATORY INVESTIGATION, 2008, 88 : 245A - 245A
  • [22] Nur 77 is a poor prognostic factor in diffuse large B-cell lymphoma
    Almiski, S.
    Razumilava, N.
    Kurrer, A.
    Frank, J.
    Levi, E.
    MODERN PATHOLOGY, 2008, 21 : 245A - 245A
  • [23] Absolute lymphocyte count is a prognostic factor in diffuse large B-cell lymphoma
    Cox, M. Christina
    Nofroni, Italo
    La Verde, Giacinto
    Ferrari, Antonella
    Amodeo, Rachele
    Tatarelli, Caterina
    Saltarelli, Francesca
    Veggia, Barbara
    Aloe-Spiriti, M. Antonietta
    Ruco, Luigi
    Monarca, Bruno
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (02) : 265 - 268
  • [24] Prognostic biomarkers in diffuse large B-cell lymphoma
    Lossos, IS
    Morgensztern, D
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) : 995 - 1007
  • [25] Prognostic markers in diffuse large B-cell lymphoma
    Delabie, Jan
    LEUKEMIA & LYMPHOMA, 2010, 51 (09) : 1588 - 1589
  • [26] Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma
    Hedstrom, Gustaf
    Berglund, Mattias
    Molin, Daniel
    Fischer, Marie
    Nilsson, Gunnar
    Thunberg, Ulf
    Book, Majlis
    Sundstrom, Christer
    Rosenquist, Richard
    Roos, Goran
    Erlanson, Martin
    Amini, Rose-Marie
    Enblad, Gunilla
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (01) : 68 - 71
  • [27] Prognostic role of neutrophil-to-lymphocyte ratio in patients with diffuse large B-cell lymphoma.
    Kushtova, Luiza B.
    Frantsiyants, Elena M.
    Bandovkina, Valeria A.
    Kozel, Yuliya Yu.
    Dmitrieva, Viktoria V.
    Kozyuk, Olga V.
    Snezhko, Aleksandr V.
    Malinin, Sergey A.
    Chalkhakhyan, Lusegen Kh.
    Kaminskiy, Gennadiy V.
    Duritskiy, Maksim N.
    Gabrichidze, Petr N.
    Vladimirova, Liubov Yu
    Lysenko, Irina B.
    Nikolaeva, Nadezhda V.
    Kit, Oleg I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] PROGNOSTIC FACTORS AND SURVIVAL OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA. DONOSTIA HOSPITAL EXPERIENCE
    Robado Juez, N.
    Millan, C.
    Lizartza, A.
    Aranbarri, A.
    Otero, I
    Sirvent, M.
    Romero, P.
    Hernandez, T.
    Alkorta, A.
    Caminos, N.
    Artola, M. T.
    Urreta, I
    Segues, N.
    Lobo, M. C.
    Araiz, M.
    Ceberio, I
    HAEMATOLOGICA, 2018, 103 : 283 - 284
  • [29] Potencial prognostic and predictive factors in diffuse large B-cell lymphoma -: the role of NFkappaB
    Flodr, P.
    Kubova, Z.
    Papajik, T.
    Tichy, M.
    Kucerova, L.
    Krejci, V.
    Fridman, E.
    EJC SUPPLEMENTS, 2008, 6 (09): : 113 - 114
  • [30] High RDW as a predictive and prognostic factor in patients with diffuse large B-cell lymphoma treated with chemoimmunotherapy.
    Paredes, Sally
    Beltran, Brady Ernesto
    Sotomayor, Eduardo M.
    Castillo, Jorge J.
    Salas, Renzo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345